ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.71
-0.56%
US Tech 100
18,307.60
0.41%
S&P 500
5,307.01
-0.27%
US Dollar vs CAD
1.36872
-0.03%
Bitcoin
69,433.39
0.48%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Oasmia Pharmaceuticals AB (OASM)

  7. Oasmia Pharmaceuticals AB (OASM) News

OASM

Oasmia Pharmaceuticals AB (OASM)

Oasmia Pharmaceuticals AB
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OASM
DateTimeSourceHeadlineSymbolCompany
03/07/20227:35AMBusiness WireCORRECTING and REPLACING Whiting and Oasis to Combine in $6.0 Billion Merger of Equals TransactionNASDAQ:OASMOasmia Pharmaceuticals AB
03/07/20226:20AMBusiness WireWhiting and Oasis to Combine in $6.0 Billion Merger of Equals TransactionNASDAQ:OASMOasmia Pharmaceuticals AB
11/27/20198:54AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OASMOasmia Pharmaceuticals AB
11/21/20198:41AMEdgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)NASDAQ:OASMOasmia Pharmaceuticals AB
08/23/20199:25AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OASMOasmia Pharmaceuticals AB
08/23/20197:01AMEdgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities Under Section 12(b) (15f-12b)NASDAQ:OASMOasmia Pharmaceuticals AB
08/21/20193:06PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
08/15/20193:06PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
08/13/20195:03AMEdgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...NASDAQ:OASMOasmia Pharmaceuticals AB
08/13/20195:00AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OASMOasmia Pharmaceuticals AB
08/08/20193:15PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:OASMOasmia Pharmaceuticals AB
08/06/20193:31PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
08/01/20193:08PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
07/09/20193:06PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
07/09/20193:06PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
07/02/20193:08PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
06/28/20193:06PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
06/26/20193:08PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
06/25/20193:06PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
05/20/201910:36AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
04/12/20193:40PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
04/04/20193:07PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
04/01/20193:10PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
04/01/20193:09PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
03/27/20193:08PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
03/25/20193:33PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
03/20/20195:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
03/06/20193:07PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
03/04/20193:06PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
03/01/20193:09PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
 Showing the most relevant articles for your search:NASDAQ:OASM

Your Recent History

BIT
P1USS3
NLBNPIT1USS3 20351219 69...
ASE
ADMIEE
Admie IPTO
POLO
XMONUSDT
XMON
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved